Presenter: Christine Le Bec, Ph.

2021/05/21

Presenter: Christine Le Bec, Ph.D. To use noodls, javascript support must be enabled.

This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Sensorion shares in any country. He will also give a presentation on Advancing Gene Therapy for Hearing Disorders: Dual AAV Manufacturing & Control Strategy, on July 21, 2022. <>

x=r?95&AT*Uq7^>l dIkF;q!g Z[AF_v/Y>_T*lsO^xn_(f70$_3{/fo|fgw"a$7?} Date: Tuesday, July 19, 2022 Hope to be able to attend next year! Privacy Policy | Terms of Use | Contact. 2 0 obj

RAPS.org needs your explicit consent to store browser cookies.

gene end commercialization integrated manufacturing enable therapy solutions biopharma asia introduction Date: Thursday, July 21, 2022 1 0 obj `I;{2#l+zA5ndrQvA>C44]jUZ$ \qpx XiV3LP.`q"jj MyKu7~lE1:kL[jML Mpp;hl4 F)iIP!D37/xN-{\FaKw'.V_!q+)Hy(#8Aj Z)QTZn( 2n#'bg#1FDMVr M!YhWX//VG1"#1]*%7P{@^lS(e W\G* 7+UZW?y\50zJe UEh( bQi^2UtV~XfS\/Q1@4 V2}n8:+!]Nfota@$7`nV@rcEyxzxs\(TY5=tV$mr KXm7Lgwge"v('TvWSv #casss #sharingsciencesolutions #celltherapy #genetherapy. Any recipient of this press release must inform oneself of any such local restrictions and comply therewith. | Company News Todays spotlight shines on Patsy Lewis, Director of CMC Development-Virtual at Tonix Pharmaceuticals. <>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.4 841.8] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>

Uy*f%Pq|,JBK;/>z\hk}`5l4 Date: Thursday, July 21, 2022

The first product, Novartis Kymriah, is approved to treat pediatric and young adult patients with B-cell acute lymphoblastic lymphoma, and products for other oncological indications are hot on its heels. Wished I could have made it this year.

stream

| Public Companies | Biotechnology | Pharmaceutical Companies Event: 7th Cell & Gene Therapy Summit. To ensure the most secure and best overall experience on our website we recommend the latest versions of, Internet Explorer is no longer supported. Learn More: https://lnkd.in/g3_mcag. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals. Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. The Symposium will be offered in a hybrid format attend live, in-person or watch the live stream from your home or office.

View the Scientific Program and Register here: https://bit.ly/3sALGCN

4 0 obj Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.

Welcome to our new website!

In this role, Ms. Tyson will help lead and grow CASSS event portfolio a key member value in a post-COVID world. Smartlinks I wasnt able to join this year but Ill try next year :), Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory, Now Hiring: Sangamo Therapeutics, Scientist II/III, Formulation - Contractor -. This will be a great symposium for anyone working to bring cell and gene therapies to patients in need. Workshop: Gene Therapy for Novel indications (Laurent Desires contribution will focus on the inner ear)

Catherine Leveau Time: 3.15 pm 4 pm SGT (9.15 am 10 am CEST) View the most up-to-date program information: https://bit.ly/3v6PF9W The goal of the CE Pharm Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide and small molecule pharmaceuticals. The CGTP 2021 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed. Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Regulatory Affairs Professionals Society. Gain a deeper understanding of the many manufacturing and industrialization hurdles unique to bringing durable and even curative therapies to patients in need.

E-mail address & Password Combo is invalid, Official encourages ATMP sponsors to consult toolbox guidance to avoid PRIME derailments, This Week at FDA: New guidance on disposable manufacturing materials, Generic Drug Cluster report, FDA blasts US API firm for lax response to mold contamination, data integrity failings, FDA finalizes guidance on including patients with incurable cancers in oncology trials, Chemistry, Manufacturing and Controls (CMC), Recon: EMA recommends Valneva COVID vaccine; Novartis wins FDA approval for Tafinlar + Mekinist combo, Fundamentals of Pharmaceutical and Biologics Regulations, Fourth Edition, Risk Management Principles for Devices and Pharmaceuticals, Good Manufacturing Practice (GMP) [4.0 RAC], Medical Devices: Corrections, Removals and Directed Recalls [6.0 RAC]. This webinar discusses the implementation of value-based payment models for innovative therapies.

If this is the first time you are logging in on the new site, you will need to reset your password. Label: SENSORION P 510.428.0740info@casss.org, The William S. Hancock Award for Outstanding Achievements in CMC Regulatory Science, CASSS Award for Outstanding Achievements in Separation Science, Frantisek Svec Fellowship for Innovative Studies, CE in the Biotechnology & Pharmaceutical Industries, Practical Applications of Mass Spectrometry in the Biotechnology Industry, Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory Considerations, Gain tangible knowledge for career advancement, Learn best practices from prominent contributors in the industry. This webinar discusses how a comprehensive control strategy for pharmaceutical products including gene therapies is the key to achieving process consistency, product quality, safety, and efficacy. endobj Even if youve been living under a rock, youre probably familiar with Bitcoin. +44 7561 424788 The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific.

Will Restaurant Week Be the Ticket? Next Generation Investigator Awards application deadline approaches! To ensure the most secure and best overall experience on our website, we recommend the latest versions of, Gene Therapy Neurological Disorders Europe. Oops! Post-Effective Amendment to Registration Statement by Investment[], Statement of Changes in Beneficial Ownership - Form 4, City to Spray July 29-30, as Two Mosquito Pools Test Positive for WNV, Amendment to Registration Statement - Specified Transactions - Form S-3/A, 07/07/2022 | Press release | Distributed by Public on 07/06/2022 23:35.

CASSS symposia and fora provide venues for biopharmaceutical It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including deafness caused by a mutation of the gene encoding for Otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries. CASSS meetings bring together industry, regulatory and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development.

Time: 4.20 pm 5.15 pm SGT (10.20 am 11.15 am CEST) This symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products. Despite the immense economic challenges brought on by COVID-19, investment interest is still strong for both public and private companies in the cell and gene therapy space. Your submission has been received! If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. | Science Early bird registration for CASSS CGTP ends tomorrow.

| Corporate and Financial Calendar Consilium Strategic Communications The WCBP Symposium series has established a reputation as the most highly-regarded annual conference addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. P 510.428.0740info@casss.org. 5900 Hollis Street Suite R3Emeryville, CA 94608 Head of Investor Relations & Communication The CGTP 2022 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed.

| OTC Markets Grab your copy today! But how will they be paid for? CASSS Moments: Front Row Seat to Challenges, CASSS Moments: Power of Connection and Sharing, CASSS Moments: CASSS Forums Leading Scientific Discussion Over the Years, CASSS Moments: Regulatory Differences: Managing Products Globally, CASSS Moments: Scientific Discussions Addressing Real-Time Issues, CASSS Moments: The Power of Regulatory Questions, CASSS Moments: Regulators and Industry Working Together to Improve Patient Outcomes, CASSS Moments: Discovering Hot Topics for Regulators, Franco Puleo, Cell & Gene Therapy Products 2022, The William S. Hancock Award for Outstanding Achievements in CMC Regulatory Science, CASSS Award for Outstanding Achievements in Separation Science, Frantisek Svec Fellowship for Innovative Studies, CE in the Biotechnology & Pharmaceutical Industries, Practical Applications of Mass Spectrometry in the Biotechnology Industry, Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory Considerations, CASSS Welcomes Necoya Tyson as the New Director of Meeting Operations. This webinar provides guidance to sponsors and developers on the best practices and recommendations in managing manufacturing changes during early development. Webcast: Update on China NMPA & US FDA Emergency Approval - Implications to Life Science Companies Relating to COVID-19. Dont miss Peter Marks, Director, CBER, FDA. Sensorion has built a unique R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and modalities for drug candidates.

| Health

A Legal Showdown Over Section 8 Discrimination Is Brewing in Dallas Suburb, Troubled Crypto Lender Babel Lost Big While Trading Client Funds, Ex-Voyager Executive Explores Competing Restructuring Plan for Crypto Lender.

3 0 obj <>/Metadata 370 0 R/ViewerPreferences 371 0 R>> Event: 7th Cell & Gene Therapy Summit, Presentation: Advancing Gene Therapy for Hearing Disorders: Dual AAV Manufacturing & Control Strategy Please contact us at raps@raps.org if you need assistance.

Visit Mission Bios virtual booth to learn about implementing single-cell analysis in advanced therapy development and our Pharma Assay Development (PAD) services. International Media Relations The populist movement promises huge returns for daring investors. The webinar includes discussion around how COVID-19 changes the way we think about healthcare decision making and places intense pressure on financial management at all levels of the health system. As more regenerative medicine products approach clinical testing and commercialization, seize this opportunity to hear detailed insights and industry best practices from preeminent sector experts. Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 Proof of Concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion@consilium-comms.com, Sensorion to present at the at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit conferences, Internet Explorer presents a security risk. | Euronext Paris, Copyright 2006-2022 Public Technologies Inc. |

Time: 2.40 pm 3.05 pm EDT (8.40 pm 9.05 pm CEST) Panel Discussion: Dealing with Post-Marketing Activities for Cell & Gene Therapy

Christine Le Bec, Ph.D., Sensorions Head of CMC Gene Therapy, will give a talk on the Characterization of Dual AAV Vector Otoferlin, on July 21, 2022, virtually, at the CASSS Bioassays Symposium, being held in Gaithersburg, MD, USA, July 19-21, 2022. The text version of this document is not available. Q>Gzlvj95:-zB,Uc%2sa~5DO#h4RxxlT cHf\%%F2WcEyxz8eG8E>XClfg[=|=t|]z7HK/uG].EX=w5LBY_..{.[|FqI;eLwKMcAx9)81f~%8fX*#~7PW{vig3;/eQ T]D'{.a_C(Wg kT3?fZKOF{9_'paA333t9j+@?uH!gmBR7EL\!9Aq~)$ Want to volunteer to facilitate or scribe for a roundtable? Regulatory Affairs Professionals Society (RAPS) NYC Wants In-Person Dining Back.

We are pleased to announce the keynote speaker for Cell and Gene Therapy Products 2022 Symposium.

This webinar features speakers Mary Beth Bosco, Nicole Elliott, and Joel Roberson, Partners at Holland & Knight LLP, to discuss the emergency loan program for small businesses established by the Coronavirus Aid, Relief, and Economic Security (CARES) Act. ISIN: FR0012596468 The CASSS Cell and Gene Therapy Products symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products. For more information, visit Cell & Gene Therapy Products, 5900 Hollis Street Suite R3Emeryville, CA 94608 But with DeFis promise of inclusion comes risk and uncertainty.

| Pharmaceuticals Please change your browser's security settings to enable javascript. Roundtable Discussions Featured at CGTP 2022 Such forward looking statements are based on assumptions that Sensorion considers to be reasonable. This webinar features FDA representatives Tejashri Purohit-Sheth and Ilan Irony from the Office of Tissues and Advanced Therapies, CBER, as they discuss the effect of COVID-19 on cell and gene therapy clinical trials. Not long now til CASSS CGTP 2022. )1[P,9GAu+0R!6gaNW-:J" r:" WN[e!sFQ@98VFP

Mnemonic: ALSEN. This webinar discussed the current funding landscape, what investors are looking for when evaluating new and follow-on opportunities, and how companies can best prepare to fundraise in the midst of the pandemic.

Sitemap 5

- le creuset enameled cast iron safe

preserved eucalyptus branches